Ambrosia Artemisiifolia Pollen: Side Effects, Uses & Monitoring

Facts extracted from current FDA product labeling for Ambrosia Artemisiifolia Pollen. Educational only — not medical advice.

Labeled uses

RAGWITEK® is an allergen extract indicated as immunotherapy for the treatment of short ragweed pollen-induced allergic rhinitis, with or without conjunctivitis, confirmed by positive skin test or in vitro testing for pollen-specific IgE antibodies for short ragweed pollen. RAGWITEK is approved for use in persons 5 through 65 years of age. RAGWITEK is not indicated for the immediate relief of allergic symptoms.

Source: FDA labeling via NIH DailyMed (set 70216cba…). Not affiliated with FDA or NIH.

Medical disclaimer: Always consult a qualified healthcare professional about any medication.

Ratings summarize government-reported measures — they don't capture your personal needs. Visit the facility, ask about staffing and services, and use CMS checklists. This profile is informational only and is not a recommendation.